477 related articles for article (PubMed ID: 34024775)
21. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina.
Saez MS; Aguirre MA; Pérez de Arenaza D; Sorroche P; Nucifora E; Posadas Martinez ML
Mol Genet Genomic Med; 2021 Nov; 9(11):e1812. PubMed ID: 34668655
[TBL] [Abstract][Full Text] [Related]
23. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
[TBL] [Abstract][Full Text] [Related]
24. [Neurological manifestations of ATTR amyloidosis].
Pernice HF; Hahn K
Inn Med (Heidelb); 2023 Sep; 64(9):848-854. PubMed ID: 37555967
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Pitfall and Clinical Characteristics of Variant Versus Wild-Type Transthyretin Amyloid Cardiomyopathy in Asian Population: The Korean Nationwide Cohort Study.
Kim D; Youn JC; Lee HW; Oh J; Son JW; Cho HJ; Lee S; Shah NR; Kittleson MM; Jeon ES
J Korean Med Sci; 2024 May; 39(19):e163. PubMed ID: 38769922
[TBL] [Abstract][Full Text] [Related]
26. Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan.
Matsushima M; Tarisawa M; Nomura T; Oshima Y; Yoshino M; Shibata Y; Wakita M; Shirai S; Iwata I; Yaguchi H; Yabe I
Intern Med; 2023 Jun; 62(11):1599-1602. PubMed ID: 36261369
[TBL] [Abstract][Full Text] [Related]
27. Cardiac manifestations and prognostic implications of hereditary transthyretin amyloidosis associated with transthyretin Ala97Ser.
Lai HJ; Huang KC; Liang YC; Chien KL; Lee MJ; Hsieh ST; Chao CC; Yang CC
J Formos Med Assoc; 2020 Mar; 119(3):693-700. PubMed ID: 31521469
[TBL] [Abstract][Full Text] [Related]
28. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
[TBL] [Abstract][Full Text] [Related]
30. Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration.
Ibrahim RB; Yeh SY; Lin KP; Ricardo F; Yu TY; Chan CC; Tsai JW; Liu YT
Cell Mol Life Sci; 2020 Apr; 77(7):1421-1434. PubMed ID: 31728576
[TBL] [Abstract][Full Text] [Related]
31. Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease.
Fenoglio R; Baldovino S; Barreca A; Bottasso E; Sciascia S; Sbaiz L; Papotti M; Roccatello D
Nephron; 2022; 146(5):481-488. PubMed ID: 35307708
[TBL] [Abstract][Full Text] [Related]
32. Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country.
Koutsis G; Kastritis E; Kontogeorgiou Z; Kartanou C; Kokotis P; Rentzos M; Breza M; Kleopa KA; Christodoulou K; Oikonomou E; Anastasakis A; Angelidakis P; Sarmas I; Kargiotis O; Tzagournissakis M; Zaganas I; Foukarakis E; Sachpekidis V; Papathoma A; Panas M; Stefanis L; Dimopoulos MA; Karadima G
Neuromuscul Disord; 2021 Dec; 31(12):1251-1258. PubMed ID: 34740514
[TBL] [Abstract][Full Text] [Related]
33. Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles.
Norgren N; Hellman U; Ericzon BG; Olsson M; Suhr OB
PLoS One; 2012; 7(11):e49981. PubMed ID: 23185504
[TBL] [Abstract][Full Text] [Related]
34. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
[TBL] [Abstract][Full Text] [Related]
35. ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin.
Gioeva Z; Urban P; Meliss RR; Haag J; Axmann HD; Siebert F; Becker K; Radtke HG; Röcken C
Amyloid; 2013 Mar; 20(1):1-6. PubMed ID: 23244293
[TBL] [Abstract][Full Text] [Related]
36. Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis.
Wu YA; Yu AL; Cheng MF; Lin LC; Lee MJ; Chou CH; Shun CT; Hsueh HW; Juang JJ; Tseng PH; Lin SP; Su MY; Chao CC; Hsieh ST; Tsai CH; Lin YH
Ther Adv Chronic Dis; 2024; 15():20406223231222828. PubMed ID: 38223905
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Barroso FA; Coelho T; Dispenzieri A; Conceição I; Waddington-Cruz M; Wixner J; Maurer MS; Rapezzi C; Planté-Bordeneuve V; Kristen AV; González-Duarte A; Chapman D; Stewart M; Amass L;
Amyloid; 2022 Sep; 29(3):175-183. PubMed ID: 35451899
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis.
Gawor M; Holcman K; Franaszczyk M; Lipowska M; Michałek P; Teresińska A; Bilińska ZT; Rubiś P; Kostkiewicz M; Szot W; Podolec P; Grzybowski J
Cardiol J; 2022; 29(6):985-993. PubMed ID: 32789836
[TBL] [Abstract][Full Text] [Related]
39. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
[TBL] [Abstract][Full Text] [Related]
40. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
